VLON

NASDAQ

Vallon Pharmaceuticals Inc.

SectorHealth CareIndustry Medicinal Chemicals and Botanical Products IPO2021

News25/Ratings1

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Latest news

25 items

811dSEC
SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
424B3 - GRI BIO, Inc. (0001824293) (Filer)
811dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
811dSEC
SEC Form 424B4 filed by Vallon Pharmaceuticals Inc.
424B4 - GRI BIO, Inc. (0001824293) (Filer)
811dSEC
SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.
EFFECT - GRI BIO, Inc. (0001824293) (Filer)
813dSEC
SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
S-1/A - GRI BIO, Inc. (0001824293) (Filer)
814dSEC
SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
S-1/A - GRI BIO, Inc. (0001824293) (Filer)
814dSEC
SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
424B3 - GRI BIO, Inc. (0001824293) (Filer)
814dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
825dSEC
SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
424B3 - GRI BIO, Inc. (0001824293) (Filer)
825dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - GRI BIO, Inc. (0001824293) (Filer)
828dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
839dSEC
SEC Form DEFA14A filed by Vallon Pharmaceuticals Inc.
DEFA14A - GRI BIO, Inc. (0001824293) (Filer)
839dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - GRI BIO, Inc. (0001824293) (Filer)
839dSEC
SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
424B3 - GRI BIO, Inc. (0001824293) (Filer)
846dSEC
SEC Form DEF 14A filed by Vallon Pharmaceuticals Inc.
DEF 14A - GRI BIO, Inc. (0001824293) (Filer)
854dSEC
SEC Form S-1 filed by Vallon Pharmaceuticals Inc.
S-1 - GRI BIO, Inc. (0001824293) (Filer)
855dSEC
SEC Form PRE 14A filed by Vallon Pharmaceuticals Inc.
PRE 14A - GRI BIO, Inc. (0001824293) (Filer)
857dSEC
SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.
EFFECT - GRI BIO, Inc. (0001824293) (Filer)
860dSEC
SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
424B3 - GRI BIO, Inc. (0001824293) (Filer)
870dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
871dSEC
SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
S-1/A - GRI BIO, Inc. (0001824293) (Filer)
878dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
881dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - GRI BIO, Inc. (0001824293) (Filer)
890dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - GRI BIO, Inc. (0001824293) (Filer)
904dSEC
Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure
8-K - GRI BIO, Inc. (0001824293) (Filer)